Evidence map›Paper›PMID 34036274›Full record

ArticleCritical care explorations2021

Volume Resuscitation and Progression to Organ Failure in Shiga Toxin-Producing

Charles G Volk, Paul M Cusmano, Richard J Bower, Terrel Sanders, Ryan C Maves

Open access · goldAbstract read
In one paragraph

Article in Critical care explorations, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Charles G VolkDepartment of Pulmonary and Critical Care Medicine, Naval Medical Center, San Diego, CA.
Paul M CusmanoDepartment of Pulmonary and Critical Care Medicine, Naval Medical Center, San Diego, CA.
Richard J BowerDepartment of Gastroenterology, Naval Medical Center, San Diego, CA.
Terrel SandersDivision of Infectious Diseases, Naval Medical Center, San Diego, CA.
Ryan C MavesDepartment of Pulmonary and Critical Care Medicine, Naval Medical Center, San Diego, CA.
Naval Medical Center San Diego · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin-producing

designWe present a case series of an Shiga toxin-producing

settingWe review the clinical course, laboratory data, and fluid resuscitation used in hospitalized patients during the 2017 Shiga toxin-producing PATIENTS: Patients admitted to the hospital for complications from Shiga toxin-producing

interventionsIsotonic crystalloid fluid resuscitation during the first 72 hours. MEASUREMENTS AND MAIN

resultsOf 244 identified cases of Shiga toxin-producing

conclusionsThe aggressive IV hydration protocols (as a percentage of body weight) in the pediatric literature may not be applicable to adults diagnosed with hemolytic uremic syndrome. A more conservative fluid strategy in adults with hemolytic uremic syndrome merits further investigation.

Indexed as

acute renal failureEscherichia coli O157:7hemolytic uremic syndromeShiga toxin-producing Escherichia coliShiga toxin-producing Escherichia coli–associated hemolytic uremic syndromevolume resuscitation

Identifiers

PMID34036274
PMCPMC8133128
OpenAlexW3162427278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.